{{Rsnum
|rsid=11912763
|Gene=MYH9
|Chromosome=22
|position=36288676
|Orientation=plus
|GMAF=0.04132
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MIR6819,MYH9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 8.8 | 43.5 | 47.6
| ASW | 0.0 | 24.6 | 75.4
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 10.0 | 90.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 7.7 | 92.3
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans
|OA=1
}}

{{PMID Auto
|PMID=20635188
|Title=Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene
|OA=1
}}
{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15
|OA=1
}}

{{PMID Auto
|PMID=22956460
|Title=Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}